Dr Lal Pathlabs: Competitor Perspective
Regional Sales Manager at Apollo Diagnostics
inpractise.com/articles/dr-lal-pathlabs-competitor-perspective
Regional Sales Manager at Apollo Diagnostics
Interview Transcript
This is a snippet of the transcript, sign up to read more.
Yes, that's what I want. At SRL and at Apollo, what are your major responsibilities?
In this B2B business, we are dealing with significant price competition. For example, if the XYZ center is not performing the thyroid stimulating hormone (TSH) test because they lack the machine, they outsource it to a nationalized lab. This leads to rate competition as they look for the cheapest outsourcing option.
This is a snippet of the transcript, sign up to read more.
Yes, that's what I want. At SRL and at Apollo, what are your major responsibilities?
They might contact Dr. Lal PathLabs, offering to send 100 TSH samples a month and ask for the per-test cost. If Dr. Lal offers them a price of 60 or 100 rupees per TSH test, they will then compare this with Metropolis or SRL's prices. This is a practical scenario currently happening in India.
This is a snippet of the transcript, sign up to read more.
And the other organizations are primarily what, just mom-and-pop shops?
Yes, exactly. There are national leaders like Dr. Lal, SRL, Apollo, Metropolis, etc. These organized players are making only 5,000 crore per annum. The market opportunity is around 85,000 crore, which is a B2B opportunity.
This is a snippet of the transcript, sign up to read more.
Related Content
Copyright Notice
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.